Intermolecular inc (IMI)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10
Revenue:
Total revenue

33,660

37,203

-

-

-

-

-

-

-

Program revenue

-

-

39,690

33,930

30,624

45,744

47,468

36,733

27,705

Product revenue

-

-

-

-

-

6,726

3,495

2,717

6,959

Licensing and royalty revenue

-

-

7,608

11,392

17,071

14,936

15,864

14,380

8,010

Total revenue

-

-

47,298

45,322

47,695

67,406

66,827

53,830

42,674

Cost of revenue:
Cost of program revenue

-

-

15,705

18,965

24,358

29,063

26,492

23,761

16,855

Cost of product revenue

-

-

-

-

-

3,175

1,635

953

3,665

Cost of licensing and royalty revenue

-

-

125

339

293

247

276

755

406

Total cost of revenue

10,008

12,105

15,830

19,304

24,651

32,485

28,403

25,469

20,926

Gross profit

23,652

25,098

31,468

26,018

23,044

34,921

38,424

28,361

21,748

Operating expenses:
Research and development

17,228

21,535

28,126

28,576

24,320

24,502

21,839

19,260

13,917

Sales and marketing

3,256

4,019

7,383

5,881

5,770

6,475

5,433

4,285

4,074

General and administrative

7,516

9,198

10,713

12,287

12,636

11,973

10,868

8,534

5,761

Restructuring charges

0

1,351

1,114

-

1,361

-

-

-

-

Restructuring charges

-

-

-

-

-

-

0

-

-

Restructuring charges

-

-

-

-

-

-

0

-

-

Total operating expenses

28,000

36,103

47,336

46,744

44,087

42,950

38,140

32,079

23,752

Income (loss) from operations

-4,348

-11,005

-15,868

-20,726

-21,043

-8,029

284

-3,718

-2,004

Other income (expense):
Interest income (expense), net

594

266

173

-267

-682

-830

-1,004

-87

43

Other income (expense), net

344

337

265

-12

-29

57

15

-26,167

202

Total other income (expense), net

938

603

438

-

-

-

-

-

-

Total other income (expense), net

-

-

-

-279

-711

-773

-989

-26,254

245

Income (loss) before provision for income taxes

-3,410

-10,402

-15,430

-21,005

-21,754

-8,802

-705

-29,972

-1,759

Provision for income taxes

1

1

7

8

7

17

51

43

19

Net income (loss)

-3,411

-10,403

-15,437

-21,013

-21,761

-8,819

-756

-30,015

-1,778

Weighted-average number of shares used in computing earnings (loss) per share
Temporary Equity, Accretion to Redemption Value

-

-

-

-

-

-

-

-8,660

-14,162

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-38,675

-15,940

Net loss per share, basic and diluted

-0.07

-0.21

-0.31

-0.44

-0.47

-0.20

-0.02

-3.99

-2.86

Weighted-average number of shares used in computing net loss per share, basic and diluted

49,689

49,547

49,396

48,158

46,718

44,958

42,966

9,698

5,567

Program Revenue
Total revenue

31,984

29,010

-

-

-

-

-

-

-

Total cost of revenue

9,999

11,449

-

-

-

-

-

-

-

Licensing and Royalty Revenue
Total revenue

1,676

8,193

-

-

-

-

-

-

-

Total cost of revenue

9

656

-

-

-

-

-

-

-

Related Party Transactions.
Total revenue

-

383

-

-

-

-

-

-

-

Total cost of revenue

-

1

-

-

-

-

-

-

-